History of ectonucleotidases and their role in purinergic signaling

H Zimmermann - Biochemical Pharmacology, 2021 - Elsevier
Ectonucleotidases are key for purinergic signaling. They control the duration of activity of
purinergic receptor agonists. At the same time, they produce hydrolysis products as …

New frontiers in the transition-metal-free synthesis of heterocycles from alkynoates: an overview and current status

I Khan, S Zaib, A Ibrar - Organic Chemistry Frontiers, 2020 - pubs.rsc.org
Heterocycles are among the well-established classes of compounds, constituting a wide
range of organic molecules. These structural motifs not only have a dominant presence in a …

Current status of N-, O-, S-heterocycles as potential alkaline phosphatase inhibitors: a medicinal chemistry overview

RS Jassas, N Naeem, A Sadiq, R Mehmood… - RSC …, 2023 - pubs.rsc.org
Heterocycles are a class of compounds that have been found to be potent inhibitors of
alkaline phosphatase (AP), an enzyme that plays a critical role in various physiological …

Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement—an in-depth review

RH Sharafat, A Saeed - Purinergic Signalling, 2024 - Springer
Ectonucleotidase inhibitors are a family of pharmacological drugs that, by selectively
targeting ectonucleotidases, are essential in altering purinergic signaling pathways. The …

Alkynoates as versatile and powerful chemical tools for the rapid assembly of diverse heterocycles under transition-metal catalysis: recent developments and …

I Khan, A Ibrar, S Zaib - Topics in Current Chemistry, 2021 - Springer
Heterocycles, heteroaromatics and spirocyclic entities are ubiquitous components of a wide
plethora of synthetic drugs, biologically active natural products, marketed pharmaceuticals …

Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor

Y Wang, C Wang, Y Zhu, Y Zhang, B Chen… - Bioorganic & Medicinal …, 2021 - Elsevier
The ATP-adenosine pathway has been recently identified as an attractive immune-oncology
target and several drug candidates have been entered clinic trials. Inspired by the report of …

Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles

A Dorababu - Heliyon, 2020 - cell.com
Global people are suffering from the legion of diseases. Cytotoxic property of the chemical
compound would not solely influence effective drug properties and reduce unnecessary side …

Synthesis, characterization, alkaline phosphatase inhibition assay and molecular modeling studies of 1-benzylidene-2-(4-tert-butylthiazol-2-yl) hydrazines

H Aziz, A Mahmood, S Zaib, A Saeed… - Journal of …, 2021 - Taylor & Francis
Alkaline phosphatases are homodimeric protein enzymes which removes phosphates from
several types of molecules. These catalyze the hydrolysis of monoesters in phosphoric acid …

Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno) therapy

SY Lee, V Namasivayam, NM Boshta, A Perotti… - RSC Medicinal …, 2021 - pubs.rsc.org
Nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) catalyzes the hydrolysis of
extracellular nucleotides. It is expressed by immune cells and some carcinomas, eg of …

Synthesis and computational studies of highly selective inhibitors of human recombinant tissue non-specific alkaline phosphatase (h-TNAP): A therapeutic target …

H Andleeb, M Hussain, SA Ejaz, J Sevigny… - Bioorganic …, 2020 - Elsevier
In this study, we have discovered small druglike molecules as selective inhibitors of human
tissue-nonspecific alkaline phosphatase (h-TNAP), an enzyme critical for the regulation of …